|
Sep 30
|
Institutional investors own a significant stake of 34% in Sight Sciences, Inc. (NASDAQ:SGHT)
|
|
Jul 25
|
Integer (ITGR) Q2 Earnings Surpass Estimates
|
|
Jun 14
|
One Sight Sciences Insider Raised Stake By 34% In Previous Year
|
|
May 7
|
Sight Sciences to Present at the Upcoming Bank of America Healthcare Conference
|
|
May 6
|
Sight Sciences, Inc. (NASDAQ:SGHT) Q1 2024 Earnings Call Transcript
|
|
May 4
|
Sight Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
May 3
|
Q1 2024 Sight Sciences Inc Earnings Call
|
|
May 2
|
Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 2
|
Sight Sciences Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Financial Guidance
|
|
Apr 30
|
Sight Sciences awarded $34m in Alcon patent infringement case
|
|
Apr 29
|
Sector Update: Health Care Stocks Edge Higher Late Afternoon
|
|
Apr 29
|
Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent for Microinvasive Glaucoma Surgery
|
|
Apr 22
|
With 34% ownership, Sight Sciences, Inc. (NASDAQ:SGHT) has piqued the interest of institutional investors
|
|
Apr 18
|
Sight Sciences to Report First Quarter Financial Results on May 2, 2024
|
|
Apr 10
|
Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at...
|
|
Apr 2
|
Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
|
|
Mar 26
|
Sight Sciences to Present at the Upcoming 23rd Annual Needham Healthcare Conference
|
|
Mar 8
|
Sight Sciences, Inc. (NASDAQ:SGHT) Q4 2023 Earnings Call Transcript
|
|
Mar 8
|
Q4 2023 Sight Sciences Inc Earnings Call
|
|
Mar 8
|
Sight Sciences Inc (SGHT) Navigates Challenges to Maintain Revenue Growth and Reduce Expenses
|